Symbol="CHRS"
AssetType="Common Stock"
Name="Coherus BioSciences Inc"
Description="Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilars and immuno-oncology market primarily in the United States. The company is headquartered in Redwood City, California."
CIK="1512762"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="444002000"
EBITDA="-225456000"
PERatio="None"
PEGRatio="0"
BookValue="-1.85"
DividendPerShare="0"
DividendYield="0"
EPS="-3.59"
RevenuePerShareTTM="2.255"
ProfitMargin="-1.452"
OperatingMarginTTM="-1.261"
ReturnOnAssetsTTM="-0.282"
ReturnOnEquityTTM="-16.57"
RevenueTTM="181928000"
GrossProfitTTM="-58399000"
DilutedEPSTTM="-3.59"
QuarterlyEarningsGrowthYOY="-0.755"
QuarterlyRevenueGrowthYOY="-0.024"
AnalystTargetPrice="12.75"
TrailingPE="-"
ForwardPE="32.89"
PriceToSalesRatioTTM="2.354"
PriceToBookRatio="73.19"
EVToRevenue="3.202"
EVToEBITDA="-3.109"
Beta="0.902"
num_52WeekHigh="14.11"
num_52WeekLow="3.6"
num_50DayMovingAverage="4.561"
num_200DayMovingAverage="6.68"
SharesOutstanding="94468000"
DividendDate="None"
ExDividendDate="None"
symbol="CHRS"
open="4.85"
high="4.88"
low="4.56"
price="4.59"
volume="1668252.00"
latest_trading_day="2023-08-09"
previous_close="4.79"
change="-0.20"
change_percent="-4.1754%"
aroon_positive_momentum_days="13"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="TRUE"
Aroon_momentum="13"
Volume_recent_avg="2785096"
Change_recent_avg="-0.03"
Delta_recent_avg="0.39"
Variance_recent_avg="0.2"
Change_ratio_recent_avg="-0.74"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="positive"
Aroon_change="TRUE"
Aroon_momentum_positive="13"
Aroon_momentum_negative="87"
image_negative_thumbnail_id_1="1098"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0131.jpeg"
image_negative_thumbnail_id_2="112"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0064.jpeg"
image_neutral_thumbnail_id_1="541"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0058.jpeg"
image_neutral_thumbnail_id_2="582"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0017.jpeg"
image_positive_thumbnail_id_1="634"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0074.jpeg"
image_positive_thumbnail_id_2="683"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0025.jpeg"
image_professor_thumbnail_id_1="1174"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
image_professor_thumbnail_id_2="1190"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
